Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,207,967 papers from all fields of science
Search
Sign In
Create Free Account
Dactylis glomerata Ab.IgG4:MCnc:Pt:Ser:Qn
Known as:
Dactylis glomerata Anticorps. IgG4:Concentration de masse:Temps ponctuel:Sérum:Quantitatif
, Dactylis glomerata As.IgG4:Massa concentratie:Moment:Serum:Kwantitatief
, Harilik kerahein antikehad.IgG4:MCnc:Pt:S:Qn
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Antibodies
Dactylis glomerata antigen
Hypersensitivity
Serum
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Sirolan phalaris and Kasbah cocksfoot prove more persistent than lucerne under drought in a medium rainfall cropping environment
Richard J. Hayes
,
Guangdi D. Li
,
M. Norton
2015
Corpus ID: 134775698
Cultivars of phalaris (Phalaris aquatica L.) and cocksfoot (Dactylis glomerata L.) suited to lower rainfall cropping environments…
Expand
2000
2000
Comparing the seasonal productivity of cocksfoot and resident pastures on hill country farms using a system model
D. Barker
2000
Corpus ID: 149448818
Grasslands Wana cocksfoot (Dactylis glomerata) has potential for use in hill country, especially dry hill country. Although Wana…
Expand
2000
2000
‘GRASSLANDS UIANA’ COCKSFOOT SEED PRODUCTION
M. Rolston
,
W. Archie
2000
Corpus ID: 73647253
‘Grasslands Wana’ cocksfoot fDacty/is glomerata), a new cultivar, produced highest seed yields (405 kg/ha over three years) at 30…
Expand
1993
1993
Selection, management and use of cocksfoot cultivars in North Island pastoral farming
S. Moloney
1993
Corpus ID: 73668716
Cocksfoot (Dactylis glomerata) is the second most commonly sown grass species after ryegrass in New Zealand farming. In 1980…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE